Growth signals Sensiva Health is expanding its leadership with a new COO as of December 2025, indicating strategic scaling and potential demand for enterprise systems, professional services, and managed operations support.

Advanced testing The company offers high-throughput RT-PCR and molecular infectious disease testing with in-house assay development and USA-made kits, presenting opportunities for equipment procurement, assay validation services, and ongoing lab automation partnerships.

Integrated platforms Recent integration with PointClickCare and a Siemens Atellica system launch suggest a focus on interoperable workflows and rapid result delivery, enabling upsell to health systems needing robust data exchange and same-day testing capabilities.

Market reach With a diverse client base including large health systems, long-term care facilities, private employers, and public health initiatives, there are multiple cross-sell avenues across healthcare providers, payers, and corporate wellness programs.

Growth readiness Revenues currently in the one to multi-million range and a lean team indicate prioritization of scalable solutions, making Sensiva a fit for managed service packages, software-as-a-service enhancements, and regional expansion initiatives.